Effect of ondansetron on intracranial pressure and cerebral perfusion pressure in patients undergoing neurosurgery;Effet de l'ondansetron sur la pression intracranienne et la pression de perfusion cerebrale chez le patient neurochirurgical

Annales Francaises d'Anesthesie et de Reanimation

Volumn 17, Issue 3, 1998, Pages 220-226

  Jacot, A ^a   Bissonnette, B ^b   Favre, J B ^c   Ravussin, P ^a,c  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^b HOSPITAL FOR SICK CHILDREN   (Canada)

^c Hopital de Sion   (Switzerland)

Author keywords

Cerebral circulation; Intracranial pressure; Neurosurgery; Ondansetron

Indexed keywords

FENTANYL; ONDANSETRON; PANCURONIUM; PROPOFOL; ANTIEMETIC AGENT; INTRAVENOUS ANESTHETIC AGENT; PLACEBO;

ADULT; AGED; ARTICLE; BRAIN CIRCULATION; BRAIN PERFUSION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; HEMODYNAMICS; HUMAN; HYPOCAPNIA; INTERMITTENT POSITIVE PRESSURE VENTILATION; INTRACRANIAL PRESSURE; INTRAVENOUS DRUG ADMINISTRATION; MALE; MEAN ARTERIAL PRESSURE; NEUROSURGERY; RANDOMIZED CONTROLLED TRIAL; ADOLESCENT; BLOOD PRESSURE; BRAIN; COMPARATIVE STUDY; DRUG EFFECT; MIDDLE AGED; PROSPECTIVE STUDY; STOMACH EMPTYING;

ADOLESCENT; ADULT; AGED; ANESTHETICS, INTRAVENOUS; ANTIEMETICS; BLOOD PRESSURE; BRAIN; CEREBROVASCULAR CIRCULATION; DOUBLE-BLIND METHOD; FEMALE; FENTANYL; GASTRIC EMPTYING; HUMANS; INJECTIONS, INTRAVENOUS; INTERMITTENT POSITIVE-PRESSURE VENTILATION; INTRACRANIAL PRESSURE; MALE; MIDDLE AGED; ONDANSETRON; PLACEBOS; PROPOFOL; PROSPECTIVE STUDIES;

EID: 0031603887     PISSN: 07507658     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0750-7658(98)80003-8     Document Type: Article

References (32)

1. 1 Garrick T, Mulvihill S, Buack S, Maeda HM, Tache Y. Intracerebroventricular pressure inhibits gastric antral and duodenal contractility but not acid secretion in conscious rabbits. Gastroenterology 1988 ; 95 : 26-31
2. 2 Naylor RJ, Rudd JA. Pharmacology of ondansetron. Eur J Anaesthesiol 1992 ; 6 : 3-10
3. 3 Andrews PL. Physiology of nausea and vomiting. Br J Anaesth 1992 ; 69 Suppl : 2-19
4. 4 Andrews PL, Hawthorn J. The neurophysiology of vomiting, Baillières Clin Gastroenterol 1988 ; 2 : 141-68
5. 5 Russel D, Kenny G. 5-HT antagonist in postoperative nausea and vomiting. Br J Anaesth 1992 ; 69 Suppl : 63-8
6. 6 Talley NJ. 5-hydroxytryptamine agonists and antagonists in the modulation of gastrointestinal motility and sensation: clinical implications. Aliment Pharmacol Ther 1992 ; 6 : 273-89
7. 7 Adams RW, Gronert GA, Sundt TJ, Michenfelder JD. Halothane, hypocapnia, and cerebrospinal fluid pressure in neurosurgery. Anesthesiology 1972 ; 37 : 510-7
8. 8 Cubeddu LX, Hoffmann IS, Fuenmayor NT, Finn AL. Efficacy of ondansetron (GR 38032F) and the role of serotonin in cisplatin-induced nausea and vomiting. N Engl J Med 1990 ; 322 : 810-6
9. 9 Kenny GN, Oates JD, Leeser J, Rowbotham DJ, Lip H, Rust M et al. Efficacy of orally administered ondansetron in the prevention of postoperative nausea and vomiting: a dose ranging study. Br J Anaesth 1992 ; 68 : 466-70
10. 10 McKenzie R, Kovac A, O'Connor T, Duncalf D, Angel J, Gratz I et al. Comparison of ondansetron versus placebo to prevent post-operative nausea and vomiting in women undergoing ambulatory gynecologic surgery. Anesthesiology 1993 ; 78 : 21-8
11. 3 antagonist ondansetron. Anesthesiology 1993 ; 78 : 15-20
12. 12 Bouly A, Nathan N, Feiss P. Prévention des nausées et vomissements postopératoires par l'ondansetron. Ann Fr Anesth Réanim 1992 ; 11 : 496-501
13. 13 Marty M, Pouillart P, Scholl S, Droz JP, Azab M, Brion N. Comparison of the 5-hydroxytryptamine 3 (serotonin) antagonist ondansetron (GR 38032F) with high-dose metoclopramide in the control of cisplatin-mduced emesis. N Engl J Med 1990 ; 322 : 816-21
14. 14 Kleinerman KB, Deppe SA, Sargent AI. Use of ondansetron for control of projectile vomiting in patients with neurosurgical trauma: two case reports. Ann Pharmaeother 1993 ; 27 : 566-8
15. 15 Baber N, Palmer JL, Frazer NM, Pritchard JF. Clinical pharmacology of ondansetron in postoperative nausea and vomiting. Eur J Anaesthesiol 1992 ; 6 : 11-8
16. 16 Heyman JS, Young ML, Bagshaw RJ, Levy WJ, Geer RT, Aukburg SJ et al. Cardiovascular stability with rapid intravenous infusion of ondansetron. Can J Anaesth 1993 ; 40 : 448-52
17. 17 Bedford TH. The effect of increased intracranial venous pressure on the pressure of the cerebrospinal fluid. Brain 1935 ; 58 : 427-47
18. 18 Ravussin P, Tempelhoff R, Modica P, Bayer-Berger M. Thiopenta-isoflurane for neurosurgical anesthesia: comparison of hemodynamics, CSF pressure and recovery. J Neurosurg Anesthesiol 1991 ; 3 : 85-95
19. 19 Matakas F, Waechter R, Knüpling R, Potolicchio SJ. Increase in cerebral perfusion pressure by arterial hypertension in brain swelling. A mathematical model of the volume-pressure relationship. J Neurosurg 1975 ; 42 : 282-9
20. 20 Williams G, Roberts PA, Smith S, Stevens FA, Tompkins P, Arancibia C. The effect of apnea on brain compliance and intracranial pressure. Neurosurgery 1991 ; 29 : 242-6
21. 21 Yoshioka M, Goda Y, Togashi H, Matsumoto M, Saito H. Pharmacological characterization of 5-hydroxytryptamine-induced apnea in the rat. J Pharmacol Exp Ther 1992 ; 260 : 917-24
22. 22 Petersen-Felix S, Arendt NL, Bak P, Bjerring P, Breivik H, Svensson P. Ondansetron does not inhibit the analgesic effect of alfentanil. Br J Anaesth 1994 ; 73 : 326-30
23. 23 Millan MJ. Serotonin and pain: evidence that activation of 5-HT1A receptors does not elicit antinociception against noxious thermal, mechanical and chemical stimuli in mice. Pain 1994 ; 58 : 45-61
24. 24 Kontos HA, Wei EP. Endothelium-dependent responses after experimental brain injury. J Neurotrauma 1992 ; 9 : 349-54
25. 25 Harper A, MacKensie E. Cerebral circulatory and metabolic effects of 5-hydroxytryptamine on pial arteriolar caliber in anesthetized cats. J Physiol 1977 ; 271 : 735-46
26. 26 Rowbotham DJ. Current management of postoperative nausea and vomiting. Br J Anaesth 1992 ; 69 Suppl : 46-59
27. 27 Watcha MF, White PF. Post-operative nausea and vomiting: do they matter? Eur J Anaesthesiol 1995 ; 10 : 18-23
28. 28 Watcha MF, White PF. New anuemetic drugs. Int Anesthesiol Clin 1995 ; 33 : 1-20
29. 29 Kenny GN. Risk factors for postoperative nausea and vomiting. Anaesthesia 1994 ; 49 Suppl : 6-10
30. 30 Hough MP, Waugaman WR. Ketorolac and propofol administration for prevention of nausea and vomiting in patients undergoing minor gynecologic surgery. Nurse Anesth 1993 ; 4 : 9-17
31. 31 Bryson J. Clinical safety of ondansetron. Semin Oncol 1992 ; 19 : 26-32
32. 32 Lamers CB. Ondansetron: effects on gastrointestinal motility. Scand J Gastroenterol 1991 ; 26 Suppl : 124-6